Skip to main content
. Author manuscript; available in PMC: 2013 Nov 18.
Published in final edited form as: AIDS. 2012 Nov 13;26(17):10.1097/QAD.0b013e328358d908. doi: 10.1097/QAD.0b013e328358d908

Table 3. Study-specific population attributable fractions.

First Author Study population HPV genotype Prevalence of
HPV genotypes in
HIV cases1 (%)		 Adjusted effect
estimate
(95% CI)		 Population
attributable fraction
(%) (95% CI2)
Averbach[24] Women, Zimbabwe Any HPV 63.4 2.4 (1.5-4.0) 37.0 (21.1-47.6)
Smith-McCune[26] Women, Zimbabwe Any HPV 50.0 1.7 (1.0-2.9) 20.8 (0-32.9)
Smith[30] Heterosexual men, Kenya Any HPV3 61.9 1.8 (1.1-2.9) 27.5 (5.6-40.6)
1

Before HIV acquisition

2

the C-I applies only to the proportion of HIV infections attributable to HPV in the individuals in these studies, and not in the wider population.

3

HPV in glans/coronal sulcus of penis